Sevelamer
Renagel (sevelamer) is a small molecule pharmaceutical. Sevelamer was first approved as Renagel on 1998-10-30. It is used to treat hyperphosphatemia in the USA. It has been approved in Europe to treat hyperphosphatemia and renal dialysis.
Trade Name | Renagel |
---|---|
Common Name | Sevelamer |
Indication | hyperphosphatemia, renal dialysis |
Drug Class | Polymers |